We report a molecular dynamics study on the solvation of EuFn(3-n) complexes in the [BMI][PF6] ionic liquid, composed of 1-butyl-3-methyl-imidazolium+ cations and PF6- anions. It is found that the most fluorinated complex in the liquid should be the EuF6(3-) species. In solution the EUF10(7-) and EuF7(4-) complexes indeed loose, respectively, 4 and 1 F anion to form the EuF6(3-) complex, while the first solvation shell of the less fluorinated complexes (n=1 to 5) is completed with 5 to 1 PF6- anions to form an octahedral first shell around Eu3+. There is one case (simulations with a "small" F model) where the EuF7(4-) complex remains stable, and cannot therefore be fully precluded. The anionic complexes are embedded in a cage formed by 6-9 BMI+ cations at ca. 8 A, hydrogen-bonded by imidazolium-CH..F- interactions. Simulations on the mixed EuF(n)Cl(6-n)3- complexes in solution and in gas phase also reveal the highest stability of EuF6(3-) compared to the mixed or the EuCl6(3-) complexes. This is confirmed by free energy perturbation calculations and results from the stronger coordination of F-, compared to Cl- ligands, as well as from better solvation of the fluoro complexes by the ionic liquid. In the gas phase, however, QM and MM calculations indicate that EuF6(3-) is unstable towards the dissociation of 1 to 2 F- ions, which points to the importance of environment and solvation forces on the stability of this octahedrally coordinated lanthanide complex.
No takes yet. Share an insight, caveat, or question.
Chaumont et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: